This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
OTC
Cyramza 500mg/50ml, concentré pour solution de perfusion
INN: X
Data updated: 2026-04-11
Available in:
🇨🇿🇩🇪🇬🇧🇸🇰
Form
—
Dosage
—
Route
—
Storage
—
About This Product
Manufacturer
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Eli Lilly (Suisse) SA (CH)
ATC Code
L01FG02
Source
SWISSMEDIC
(
ARTG
)
CYRAMZA , in combination with paclitaxel, is indicated for the treatment of adult patients with advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma with disease progression after prior platinum and fluropyrimidine chemotherapy.
CYRAMZA, as monotherapy, is indicated for the treatment of adult patients with advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma with disease progression after prior platinum or fluoropyrimidine chemotherapy when treatment in combination with paclitaxel is not appropriate.